杂志简称：iran j pharm res
中文译名：《伊朗药学研究杂志》
收录属性：scie（2024版）, 英文期刊,
自引率：3.30%
投稿方向：医学、pharmacology & pharmacy 药学
SCI/E期刊基本信息
出版周期：季刊 地区：伊朗
中科院分区：4区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：OA期刊
国际标准刊号：ISSN1735-0328；EISSN1726-6890
杂志语言：英语
出版国家：伊朗
杂志官网 联系方式
出版地址：SHAHEED BEHESHTI UNIV,SCH PHARMACY,NO 10 SHAMS ALLEY,VALI-E ASR ST,TEHRAN,IRAN,00000
杂志邮箱：
投稿网址：http://ijpr.sbmu.ac.ir/author
杂志官方网址：http://ijpr.sbmu.ac.ir/
出版商网址：
杂志投稿要求
投稿须知【杂志社官方网站信息】
Instructions for Authors updated September 2020
Introduction
The Iranian Journal of Pharmaceutical Research (IJPR) is a peer-reviewed multi-disciplinary pharmaceutical publication published quarterly to serve as a means for scientific information exchange in the international pharmaceutical forum. It accepts submission of original research not published or under consideration for publication anywhere else. Specific topics of interest to the journal include, but not limited to: pharmaceutics, industrial pharmacy, pharmacognosy, toxicology, medicinal chemistry, radiopharmacy, novel analytical methods for drug characterization, computational and modeling approaches to drug design, bio-medical experience, clinical investigation, rational drug prescribing, pharmacoeconomics, pharmacoepidemiology, pharmaceutical policy, pharma management, biotechnology, nanotechnology, biopharmaceutics and physical pharmacy. The paper must report novel findings based on an extensive and thorough study. Papers with didactic orientation, bulletins and subjects of exclusively local interest will not be considered for publication.
Full Disclosure
The manuscript should provide full and appropriate credit to all who contributed to the experimental data and their interpretation and discussion. Each manuscript must be accompanied by a cover letter signed by the corresponding author on behalf of all the authors that its publication has been approved by all coauthors, if any, as well as by the responsible authorities at the institute where the work has been carried out. The cover letter should explicitly state that the manuscript has not been previously published in any language anywhere (except in the form of an abstract or as part of a published lecture, review, or thesis) and that it is not under simultaneous consideration by another journal. Moreover, Iranian Journal of Pharmaceutical Research will not publish any manuscript unless the chemical structures of all compounds are fully disclosed, either by reference to prior work providing such data or by enclosure of such data in the manuscript.
Copyright Transfer
A statement transferring copyright from the authors (or their employers, if they hold the copyright) to School of Pharmacy, Shahid Beheshti University of Medical Sciences will be required before the manuscript can be accepted for publication.
All the articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g. as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic databases, video disks, etc. without first obtaining written permission from the publisher. The use of general descriptive names, trade names, trademarks, in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
Ethics in Animal and Clinical Investigations
Investigation using experimental animals must contain a statement confirming the adherence of the research to the ethics guidelines of the institute. Investigation involving human subjects should be in accordance with the Helsinki Declaration of 1975 (revised in 2008) and be approved by the institutional ethics committee or equivalent; and this should be stated in the “Methods” section.
In case of any doubt about the adherence of the research to the Helsinki Declaration, it should be demonstrated that the doubtful aspects have been explicitly approved by the relevant institutional ethics committee, and the rational for the approach should be explained.
In clinical studies involving human subjects, the patient’s right to privacy should be considered and any form of identifying information should not be published unless this is necessary for scientific purposes and the patient gives written informed consent. In this case, this should be indicated in the manuscript. Manuscripts reporting clinical trial data should provide the registration number of the study in the text of the manuscript.